However, often initially responsive GBM tumors develop resistance to BCNU and temozolomide and these treatments become ineffective due to the DNA repair mediated by the enzyme O6-methylguanine-DNA methyltransferase (MGMT) [16,17]. The gene discussed is MGMT; the disease is glioblastoma.